Vetoquinol SA

XPAR:VETO (France)  
€ 102.20 (+2.4%) Jun 7
21.74
P/B:
2.29
Market Cap:
€ 1.21B ($ 1.30B)
Enterprise V:
€ 1.08B ($ 1.16B)
Volume:
5.24K
Avg Vol (2M):
3.06K
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Vetoquinol SA ( ) from 2006 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Vetoquinol stock (XPAR:VETO) PE ratio as of Jun 10 2024 is 21.74. More Details

Vetoquinol SA (XPAR:VETO) PE Ratio (TTM) Chart

To

Vetoquinol SA (XPAR:VETO) PE Ratio (TTM) Historical Data

Total 1272
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Vetoquinol PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 21.7 2024-04-05 20.5
2024-06-07 21.7 2024-04-04 20.5
2024-06-06 21.2 2024-04-03 20.6
2024-06-05 21.1 2024-04-02 20.8
2024-06-04 21.4 2024-03-28 21.2
2024-06-03 22.0 2024-03-27 21.3
2024-05-31 21.7 2024-03-26 21.1
2024-05-30 21.6 2024-03-25 21.1
2024-05-29 21.6 2024-03-22 21.4
2024-05-28 21.6 2024-03-21 21.0
2024-05-27 22.1 2024-03-20 20.6
2024-05-24 22.3 2024-03-19 21.9
2024-05-23 22.3 2024-03-18 22.4
2024-05-22 22.3 2024-03-15 22.0
2024-05-21 21.7 2024-03-14 22.2
2024-05-20 21.9 2024-03-13 22.1
2024-05-17 21.5 2024-03-12 22.6
2024-05-16 21.1 2024-03-11 22.2
2024-05-15 21.3 2024-03-08 22.3
2024-05-14 21.1 2024-03-07 21.9
2024-05-13 20.8 2024-03-06 21.8
2024-05-10 20.9 2024-03-05 21.7
2024-05-09 20.7 2024-03-04 21.8
2024-05-08 20.2 2024-03-01 21.4
2024-05-07 20.3 2024-02-29 21.4
2024-05-06 20.0 2024-02-28 21.4
2024-05-03 20.1 2024-02-27 21.3
2024-05-02 20.3 2024-02-26 20.9
2024-04-30 20.1 2024-02-23 21.3
2024-04-29 21.0 2024-02-22 21.4
2024-04-26 21.2 2024-02-21 21.4
2024-04-25 20.9 2024-02-20 21.3
2024-04-24 21.3 2024-02-19 21.3
2024-04-23 21.0 2024-02-16 21.5
2024-04-22 20.8 2024-02-15 21.5
2024-04-19 20.4 2024-02-14 21.7
2024-04-18 20.1 2024-02-13 21.7
2024-04-17 20.8 2024-02-12 22.0
2024-04-16 20.6 2024-02-09 21.4
2024-04-15 20.7 2024-02-08 21.6
2024-04-12 20.4 2024-02-07 21.9
2024-04-11 20.6 2024-02-06 22.3
2024-04-10 20.3 2024-02-05 22.3
2024-04-09 20.5 2024-02-02 21.8
2024-04-08 20.7 2024-02-01 22.4

Vetoquinol SA (XPAR:VETO) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.